Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Phase III trial shows safety/tolerability of BG-12 in MS

Oct. 25, 2011

AMG-827 improves quality of life in patients with plaque psoriasis

Oct. 25, 2011

Phase II and III data presented on vorinostat

Oct. 25, 2011

Therapy benefits children with Tay-Sachs and Sandhoff's diseases / News in Context

Oct. 25, 2011

Study finds biomarkers of metastatic disease progression in prostate cancer

Oct. 25, 2011

First-in-human AVI-6003 trial advances

Oct. 24, 2011

Phase II trials assess belinostat in bladder cancer and hepatocellular carcinoma

Oct. 24, 2011

Pazopanib activity reported in soft tissue sarcoma and urothelial cancer

Oct. 24, 2011

Study suggests montelukast improves pediatric atopic dermatitis

Oct. 24, 2011

Findings disclosed from ATON study evaluating atacicept in optic neuritis

Oct. 21, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...